The role of eIF3 and its individual subunits in cancer

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 7, 2015, Pages 792-800

  Hershey, John W B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; EIF3; Initiation factors; Protein synthesis; Translational control

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 3; INITIATION FACTOR 3A; INITIATION FACTOR 3B; INITIATION FACTOR 3C; INITIATION FACTOR 3E; INITIATION FACTOR 3F; INITIATION FACTOR 3H; INITIATION FACTOR 3I; INITIATION FACTOR 3M; MERLIN; MESSENGER RNA; SMALL INTERFERING RNA; TANESPIMYCIN; UNCLASSIFIED DRUG; METHIONINE TRANSFER RNA; PROTEIN SUBUNIT; RNA; TUMOR PROTEIN;

BLADDER TUMOR; BREAST CANCER; CELL PROLIFERATION; CRYSTAL STRUCTURE; GENE EXPRESSION; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; IMMORTALIZED CELL LINE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MELANOMA B16; NEOPLASM; NON SMALL CELL LUNG CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; PROTEIN SUBUNIT;

ANIMALS; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-3; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEIN SUBUNITS; RNA, MESSENGER; RNA, NEOPLASM; RNA, TRANSFER, MET;

EID: 84930820319     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.10.005     Document Type: Review

References (145)

1. Ruggero D. Translation control in cancer etiology. Protein Synthesis and Translational Control 2012, 253-279. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. J.W.B. Hershey, N. Sonenberg, M.B. Mathews (Eds.).
2. Silvera D., Formenti S.C., Schneider R.J. Translational control in cancer. Nat. Rev. Cancer 2010, 10:254-266.
3. Ingolia N., Ghaemmaghami S., Newman J., Weissman J. Geome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 2009, 324:218-223.
4. Spilka R., Ernst C., Mehta A.K., Haybaeck J. Eukaryotic translation initiation factors in cancer development and progression. Cancer Lett. 2013, 340:9-21.
5. Hinnebusch A.G. The scanning mechanism of eukaryotic translation initiation. Annu. Rev. Biochem. 2014, 83:779-812.
6. Hinnebusch A.G., Lorsch J.R. The mechanism of eukaryotic translation initiation: new insights and challenges. Protein Synthesis and Translational Control 2012, 29-53. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. J.W.B. Hershey, N. Sonenberg, M.B. Mathews (Eds.).
7. Valasek L.S. "Ribozoomin"-translation initiation from the perspective of the ribosome-bound eukaryotic initiation factors (eIFs). Curr. Protein Pept. Sci. 2012, 13:305-330.
8. Lomakin I.B., Steitz T.A. The initiation of mammalian protein synthesis and mRNA scanning mechanism. Nature 2013, 500:307-311.
9. Benne R., Hershey J.W.B. Purification and characgerizagion of initiation factor IF-E3 from rabbit reticulocytes. J. Biol. Chem. 1976, 73:3005-3009.
10. Smith K.E., Henshaw E.C. Binding of Met-tRNAf to native ribosoma subunits in Ehrlich ascites tumor cells. J. Biol. Chem. 1975, 250:6880-6884.
11. Fraser C.S., Lee J.Y., Mayeur G.L., Bushell M., Doudna J.A., Hershey J.W.B. The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40S ribosomal subunits in vitro. J. Biol. Chem. 2004, 279:8946-8956.
12. Sokabe M., Fraser C.S. Human eIF2-GTP-Met-tRNAi ternary complex and eIF3 stabilize the 43S preinitiation complex. J. Biol. Chem. 2014, (in press).
13. Sokabe M., Fraser C.S., Hershey J.W.B. The human translation initiation multi-factor complex promotes methionyl-tRNAi binding to the 40S ribosomal subunit. Nucleic Acids Res. 2012, 40:905-913.
14. Ozes A.R., Feoktistova K., Avanzino B.C., Fraser C.S. Duplex unwinding and ATPase activities of the DEAD-Box helicase eIF4A are coupled by eIF4G and eIF4B. J. Mol. Biol. 2011, 412:674-687.
15. Feoktistova K., Tuvshintogs E., Do A., Fraser C.S. Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:13339-13344.
16. Korneeva N.L., Lamphear B.J., Hennigan F.L., Rhoads R.E. Mutually coooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eF4G-1. J. Biol. Chem. 2000, 275:41369-41376.
17. Villa N., Do A., Hershey J.W.B., Fraser C.S. Human eIF4G binds eIF3c, -d and -e to promote mRNA recruitment to the ribosome. J. Biol. Chem. 2013, 288:32932-32940.
18. Korneeva N.L., Lamphear B.J., Hennigan F.L.C., Merrick W.C., Rhoads R.E. Characterization of the two eIF4A-binding sites on human eIF4G-1. J. Biol. Chem. 2001, 276:2872-2879.
19. Kahvejian A., Roy G., Sonenberg N. The mRNA closed-loop model: the function of PABP and PABP-interacting proteins in mRNA translation. Cold Spring Harb. Symp. Quant. Biol. 2001, 66:293-300.
20. Sachs A. Physical and functional interactions between the mRNA cap structure and the poly(A) tail. Translational Control of Gene Expression 2000, 447-466. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. N. Sonenberg, J.W. Hershey, M.B. Mathews (Eds.).
21. Martineau Y., Derry M.C., Wang X., Yanagiya A., Berlanga J.J., Shyu A.B., Imataka H., Gehring K., Sonenberg N. Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol. Cell. Biol. 2008, 28:6658-6667.
22. Martineau Y., Wang X., Alain T., Petroulakis E., Shahbazian D., Fabre B., Bousquet-Dubouch M.P., Monsarrat B., Pyronnet S., Sonenberg N. Control of Paip1-eukaryotic translation initiation factor 3 interaction by amino acids through S6 kinase. Mol. Cell. Biol. 2014, 34:1046-1053.
23. Buschell M., Wod W., Varpenter G., Pain V.M., Morley S.J., Clemens M.J. Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. J. Biol. Chem. 2001, 276:23922-23928.
24. Fraser C.S., Berry K.E., Hershey J.W.B., Doudna J.A. eIF3j is located in the decoding center of the human 40S ribosomal subunit. Mol. Cell 2007, 26:811-819.
25. Wagner S., Herrmannova A., Malik R., Peclinovska L., Valasek L. Functional and biochemical characterization of human eIF3 in living cells. Mol. Cell. Biol. 2014, 34:3041-3052.
26. Pisarev A.V., Kolupaeva V.G., Yusupov M.M., Hellen C.U.T., Pestova T.V. Ribosomal position and contacts of mRNA in eukaryotic translation initiation complexes. EMBO J. 2008, 27:1609-1621.
27. Poyry T.A.A., Kaminski A., Jackson R.J. What determines whether mammalian ribosomes resume scanning after translation of a short upstream open reading frame?. Genes Dev. 2004, 18:62-75.
28. Beznoskova P., Cuchalova L., Wagner S., Shoemaker C.J., Gunisova S., von der Haar T., Valasek L.S. Translation initiation fators eIF3 and HCR1 control trnaslation termination and stop codon read-through in yeast cells. PLoS Genet. 2013, 9:e1003962.
29. Pisarev A.V., Hellen C.U.T., Pestova T.V. Recycling of eukaryotic post-termination ribosomal complexes. Cell 2007, 131:286-299.
30. Skabkin M.A., Skabkina O.V., Hellen C.U., Pestova T.V. Reinitiation and other unconventional posttermination events during eukaryotic translation. Mol. Cell 2013, 51:249-264.
31. Fraser C.S., Doudna J.A. Structural and mechanistic insights into hepatitis C viral translation initiation. Nat. Rev. Microbiol. 2007, 5:29-38.
32. Siridechadilok B., Fraser C.S., Hall R.J., Doudna J.A., Nogales E. Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science 2005, 310:1513-1515.
33. Sun C., Querol-Audi J., Mortimer S.A., Arias-Palomo E., Doudna J.A., Nogales E., Cate J.H.D. Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation. Nucleic Acids Res. 2013, 41:7512-7521.
34. Cai Q., Todorovic A., Andaya A., Gao J., Leary J.A., Cate J.H.D. Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit. J. Mol. Biol. 2010, 403:185-196.
35. Ujino S., Nishitsuji H., Sugiyama R., Suzuki H., Hishiki T., Sugiyama K., Shimotohno K., Takaku H. The interaction between human initiation factor eIF3 subunit c and heat-shock protein 90: a necesssary factor for translation mediated by the hepatitis C virus internal ribosome entry site. Virus Res. 2012, 163:390-395.
36. Hashem Y., des Georges A., Dhote V., Langlois R., Liao H.Y., Grassucci R.A., Pestova T.V., Hellen C.U.T., Frank J. Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit. Nature 2013, 503:539.
37. Souii A., Gharbi J., M'hadheb-Gharbi M.B. Impaired binding of standard initiation factors eIF3b, eIF4G and eIF4B to domain V of the live-attenuate coxsackievirus B3 Sabin3-like IRES-alternatives for 5'UTR-related cariovirulence mechanisms. Diagn. Pathol. 2013, 8(1):161.
38. Yin J.Y., Dong Z.Z., Liu R.Y., Chen J., Liu Z.Q., Zhang J.T. Translation regulation of RPA2 via internal ribosomal entry site and by eIF3a. Carcinogenesis 2013, 34:1224-1231.
39. Komarova A.V., Real E., Borman A.M., Brocard M., England P., Tordo N., Hershey J.W.B., Kean K.M., Jacob Y. Rabies virus matrix protein interplay with eIF3, new inights into rabies virus pathogenesis. Nucleic Acids Res. 2007, 35:1522-1532.
40. Wen F., Zhou R., Shen A., Choi A., Uribe D., Shi J. The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS ONE 2012, 7(3):e34194.
41. Methot N., Song M.S., Sonenberg N. A region rich in aspartic acid, arginine, tyrosine and glycine (DRYG) mediates eukaryotic intiaition factor 4B (eIF4B) self-association and interction with eIF3. Mol. Cell. Biol. 1996, 16:5328-5334.
42. Holz M.K., Ballif B., Gygi S.P., Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005, 123:569-580.
43. Isken O., Kim Y.K., Hosoda N., Mayeur G.L., Hershey J.W.B., Maquat L.E. Upf1 phosphorylation triggers translational repression during nonsense-medicated mRNA decay. Cell 2008, 133:314-327.
44. Flury V., Restuccia U., Bachi A., Muhlemann O. Characterization of phosphorylation- and RNA-dependent UPF1 interactors by quantitative proteomics. J. Proteome Res. 2014, 13:3038-3053.
45. Salsman J., Pinder J., Tse B., Corkery D., Dellaire G. The translation initiation factor 3 subunit eIF3k interacts with PML and associates with PML nuclear bodies. Exp. Cell Res. 2013, 319:2554-2565.
46. Aitken C.E., Lorsch J.R. A mechanistic overview of translation initiation in eukaryotes. Nat. Struct. Mol. Biol. 2012, 19:568-576.
47. Erzberger J.P., Stengel F., Pellarin R., Zhang S., Schaefer T., Aylett C.H., Cimeermancic P., Boehringer D., Sali A., Aebersold R., Ban N. Molecular architecture of the 40S-eIF1-eIF3 translation initiation complex. Cell 2014, 158:1123-1135.
48. Dong Z., Zhang J. Initiation factor eIF3 and regulation of mRNA translation, cell growth and cancer. Crit. Rev. Oncol. Hematol. 2006, 59:169-180.
49. Hinnebusch A.G. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 2006, 31:553-562.
50. Naranda T., MacMillan S.E., Hershey J.W.B. Initiation factor eIF-3 is an RNA-binding protein complex that contains the PRT1 protein. J. Biol. Chem. 1994, 269:32286-32292.
51. Smith M.D., Gu Y., Querol-Audi J., Vogan J.M., Nitido A., Cate J.H.D. Human-like eukaryotic translation initiation factor 3 from Neurospora crassa. PLoS ONE 2013, 8:e78715.
52. Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L., Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol. Cell. Proteomics 2007, 6:1135-1146.
53. Zhou C., Arslan F., Wee S., Krishnan S., Ivanov A.R., Oliva A., Leatherwood J., Wolf D.A. PCI proteins eIF3e and eIF3m define distinct translation initiation factor 3 complexes. BMC Biol. 2005, 3:14.
54. Pick E., Hofmann K., Glickman M.H. PCI complexes: beyond the proteasome, CSN and eIF3 Troika. Mol. Cell 2009, 35:260-264.
55. Hashem Y., des Georges A., Dhote V., Langlois R., Liao H.Y., Grassucci R.A., Hellen C.U.T., Pestova T.V., Frank J. Structure of the mammalian ribosomal 43S preinitiation complex bound to the scanning factor DHX29. Cell 2013, 153:1108-1119.
56. Sun C., Todorovic A., Querol-Audi J., Bai Y., Villa N., Snyder M., Ashchyan J., Lewis C.S., Hartland A., Gradia S., Fraser C.S., Doudna J.A., Nogales E., Cate J.H.D. Functional reconstitution of human eukaryotic translation initiation factor 3 (eIF3). Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20473-20478.
57. Lingaraju G.M., Bunker R.D., Cavadini S., Hess D., Hassiepen U., Renatus M., Fischer E.S., Thoma N.H. Crystal structure of the human COP9 signalosome. Nature 2014, 10.1038/nature13566.
58. Shen X., Yang Y., Leu W., Sun M., Jiang J., Zong H., Gu J. Crystal structure of human eIF3k, the first structure of eIF3 subunits. J. Biol. Chem. 2004, 279:34983-34990.
59. Herrmannova A., Daujotyte D., Yang J.C., Cuchalova L., Gorrec F., Wagner S., Danyi I., Lukavsky P.J., Valasek L.S. Structural analysis of an eIF3 subcomplex reveals conserved interactions required for a stable and proper translation pre-initiation complex assembly. Nucleic Acids Res. 2012, 40:2294-2311.
60. Liu Y., Neumann P., Kuhle B., Monecke T., Schell S., Chari A., Ficner R. Translation initiation factor eIF3b contains a nine-bladed β-propeller and interacts with the 40S ribosomal subunit. Structure 2014, 22:923-930.
61. ElAntak L., Wagner S., Hermannova A., Karaskova M., Rutkai E., Lukavsky P.J., Valasek L. The indispensable N-terminal half of eIF3j/HCR1 cooperates with its structurally conserved binding partner eIF3b/PRT1-RRM and with eIF1A in stringent AUG selection. J. Mol. Biol. 2010, 396:1097-1116.
62. Khoshnevis S., Neumann P., Ficner R. Crystal structure of the RNA recognition motif of yeast translation initiation factor eIF3b reveals differences to human eIF3b. PLoS ONE 2010, 5(9):e12784.
63. Khoshnevis S., Gunisova S., Vickova V., Kouba T., Neumann P., Beznoskova P., Ficner R., Valasek L. Structural integrity of the PCI domain of eIF3a/TIF32 is required for mRNA recruitment to the 43S preinitiation complexes. Nucleic Acids Res. 2014, 42:4123-4139.
64. Zhou M., Sandercock A.M., Fraser C.S., Ridlova G., Stephens E., Schenauer M.R., Yokoi-Fong T., Barsky D., Leary J.A., Hershey J.W.B., Doudna J.A., Robinson C.V. Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18139-18144.
65. Masutani M., Sonenberg N., Yokoyama S., Imataka H. Reconstitution reveals the functional core of mammalian eIF3. EMBO J. 2007, 26:3373-3383.
66. Querol-Audi J., Sun C., Vogan J.M., Smith M.D., Gu Y., Cate J.H.D., Nogales E. Architecture of human translation initiation factor 3. Structure 2013, 21:1-9.
67. Masutani M., Machida K., Kobayashi T., Yokoyama S., Imataka H. Reconstitution of eukaryotic translation initiation factor 3 by co-expression of the subunits in a human cell-derived in vitro protein synthesis system. Protein Expr. Purif. 2013, 87:5-10.
68. Dong Z., Jing Q., Jianguo L., Zhang J.T. Spectrin domain of eukaryotic initiation factor 3a is the docking site for formation of the a:b:i:g subcomplex. J. Biol. Chem. 2013, 288:27951-27959.
69. Zeng L., Wan Y., Li D., Wu J., Shao M., Chen J., Hui L., Ji H., Zhu X. The m subunit of murine translation initiation factor eIF3 maintains the integrity of the eIF3 complex and is required for embryonic development, homeostasis, and organ size control. J. Biol. Chem. 2013, 288:30087-30093.
70. Zhang L., Pan X., Hershey J.W.B. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J. Biol. Chem. 2007, 282:5790-5800.
71. Roobol A., Roobol J., Carden M.J., Smith M.E., Hershey J.W., Bastide A., Knight J.R., Willis A.E., Smales C.M. The chaperonin CCT interacts with and mediates the correct folding and activity of three subunits of translation initiation factor eIF3: b, i and h. Biochem. J. 2014, 458:213-224.
72. Bachmann F., Banziger R., Burger M.M. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer Res. 1997, 57:988-994.
73. Dellas A., Torhorst J., Bachmann F., Baenziger R., Schultheiss E., Burger M.M. Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 1998, 83:1376-1383.
74. Chen G., Burger M.M. p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int. J. Cancer 1999, 84:95-100.
75. Chen G., Burger M.M. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. Int. J. Cancer 2004, 112:393-398.
76. Lin L., Holbro T., Alonso G., Gerosa D., Burger M.M. Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7. J. Cell. Biochem. 2001, 80:483-490.
77. Haybaeck J., O'Connor T., Spilka R., Spizzo G., Ensinger C.H., Mikuz G., Brunhuber T., Vogetseder A., et al. Overexpression of P150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer. Anticancer Res. 2010, 30:1047-1055.
78. Pincheira R., Chen Q., Zhang J.T. Identification of a 170-kDa protein over-expressed in lung cancers. Br. J. Cancer 2001, 84:1520-1527.
79. Dong Z., Liu L.H., Cui P., Pincheira R., Yanng Y., et al. Role of eIF3a in regulating cell cycle progression. Exp. Cell Res. 2009, 315:1889-1894.
80. Dong Z., Liu L.H., Han B., Pincheira R., Zhang J.T. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 2004, 23:3790-3801.
81. Chaudhuri J., Chakrabarti A., Maitra U. Biochenical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1. J. Biol. Chem. 1997, 272:30975-30983.
82. Dong Z., Zhang J.T. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol. Biol. Cell 2003, 14:3942-3951.
83. Lane D.J.R., Saletta F., Rahmanto Y.S., Kovacevic Z., Richardson D.R. N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion. PLoS ONE 2013, 8:e57273.
84. Liu R.Y., Dong Z., Liu J., Yin J.Y., Zhou L., Wu X., Yang Y., Mo W., Huang W., Khoo S.K., Chen J., Petillo D., Teh B.Y., Qian C.N., Zhang J.T. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma. Oncogene 2011, 30:4814-4823.
85. Yin J.Y., Shen J., Dong Z.Z., Huang Q., Zhong M.Z., Feng D.Y., Zhou H.H., Zhang J.T., Liu Z.Q. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. Clin. Cancer Res. 2011, 17:4600-4609.
86. Shen J., Yin J.Y., Li X.P., Liu Z.Q., Wang Y., Chen J., Qu J., Xu X.J., McLeod H.L., He Y.J., Xia K., Jia Y.W., Zhou H.H. The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PLoS ONE 2014, 9:e96008.
87. Naranda T., Strong W.B., Menaya J., Fabbri B.J., Hershey J.W.B. Two structural domains of initiation factor eIF-4B are involved in binding to RNA. J. Biol. Chem. 1994, 269:14465-14472.
88. MacDonald J.I., Verdi J.M., Meakin S.O. Activity-dependent interaction of the intracellular domain of rat trkA with intermediate filament proteins, the beta-6 proteasomal subunit, Ras-GRF1, and the p162 subunit of eIF3. J. Mol. Neurosci. 1999, 13:141-158.
89. Unhavaithaya Y., Hao Y., Beyret E., Yin H., Kuramochi-Miyagawa S., Takano T., Lin H. MILI, a PIWI-interacting RNA-binding protein, is required for germ line stem cell self-renewal and appears to positively regulate translation. J. Biol. Chem. 2009, 284:6507-6519.
90. Wang H., Ru Y., Sanchez-Carbayo M., Wang X., Kieft J.S., Theodorescu D. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clin. Cancer Res. 2013, 19:2850-2860.
91. ElAntak L., Tzakos A.G., Locker N., Lukavsky P.J. Structure of eIF3b RNA recognition motif and its interaction with eIF3j: structural insights into the recruitment of eIF3b to the 40S ribosomal subunit. J. Biol. Chem. 2007, 282:8165-8174.
92. Fathinajafabadi A., Perez-Jimenez E., Riera M., Knecht E., Gonzalez-Duarte R. CERKL, a retinal disease gene, encodes an mRNA-binding protein that localizes in compact and untranslated mRNPs associated with microtubules. PLoS ONE 2014, 9(2):e87898.
93. Lee K.H., Kim S.H., Kim W., Lee H.R., Jung Y., Choi J.H., Hong K.Y., Jang S.K., Kim K.T. AUF1 contributes to Cryptochrome1 mRNA degradation and rhythmic translation. Nucleic Acids Res. 2014, 42:3590-3606.
94. Rothe M., Ko Y., Albers P., Wernert N. Eukaryotic initiation factor 3 p110 mRNA is overexpressed in testicular seminomas. Am. J. Pathol. 2000, 157:1597-1604.
95. Scoles D.R., Yong W.H., Qin Y., Wawrowsky K., Pulst S.M. Schwammonin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c). Hum. Mol. Genet. 2006, 15:1059-1070.
96. Song N., Wang Y., Gu X.-D., Chen Z.-Y., Shi L.-B. Effect of siRNA-mediated knockdown of eIF3c gene on survival of colon cancer cells. J. Zhejiang Univ. Sci. B 2013, 14:451-459.
97. Luftus B.J., et al. Genome duplications and other features in 12Mb of DNA sequence from human chromosome 16p and 16q. Genomics 1999, 60:295-308.
98. Gildea D.E., Luetkemeier E.S., Bao X., Loftus S.K., Mackem S., Ynag Y., Pavan W.J., Bisecker L.G. The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling. FASEB J. 2011, 25:1596-1605.
99. Marchetti A., Buttitta F., Miyazaki K., Smith G.H., Diella F., Gallahan D., Callahan R. Int-6, a widely expressed, highly conserved gene is mutated by MMTV insertion in mammary hyperplasia. J. Virol. 1995, 69:1932-1938.
100. Marchetti A., Buttitta F., Pellegrini S., Bertacca G., Callahan R. Reduced expression of INT-6/eIF3-p48 in human tumors. Int. J. Oncol. 2001, 18:175-179.
101. Buttitta F., Martella C., Barassi F., Felicioni L., Salvatore S., Rosini S., et al. Int6 expression an predict survival in early-stage non-small cell lung cancer patients. Clin. Cancer Res. 2005, 11:3198-3204.
102. Rasmussen S.B., Buttitta F., Callahan R., Smith G.H. Evidence for the transforming activity of a truncated Int6 gene, in vitro. Oncogene 2001, 20:5291-5301.
103. Mayeur G.L., Hershey J.W.B. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e). FEBS Lett. 2002, 514:49-54.
104. Sesen J., Cammas A., Scotland S.J., Elafterion B., Lemarie A., Millevoi S., Mathew L.K., Seva C., Toulas C., Moyal E.C., Skuli N. Int6/eIF3e is essential for proliferation and survival of human glioblastoma cells. Int. J. Mol. Sci. 2014, 15:2172-2190.
105. LeFebvre A.K., Korneeva N.L., Trutschl M., Cvek U., Duzan R.D., Bradley C.A., Hershey J.W.B., Rhoads R.E. Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit. J. Biol. Chem. 2006, 281:22917-22932.
106. Chiluiza D., Bargo S., Callahan R., Rhoads R.E. Expression of truncated eukaryoti initiation factor 3e (eIF3e) resulting from integration of mouse mammary tumor virus (MMTV) causes a shift from cap-dependent to cap-independent translation. J. Biol. Chem. 2011, 286:31288-31296.
107. Walsh D., Mohr I. Coupling 40S ribosome recruitment to modification of a cap-binding initiation factor by eIF3 subunit e. Genes Dev. 2014, 28:835-840.
108. Hui D.J., Bhasker C.R., Merrick W.C., Sen G.C. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNA. J. Biol. Chem. 2003, 278:39477-39482.
109. Neusiedler J., Mocquet V., Limousin T., Ohlmann T., Morris C., Jalinot P. INT6 interacts with MIF4GD/SLIP1 and is necessary for efficient histone mRNA translation. RNA 2012, 18:1163-1177.
110. Buda P., Reinbothe T., Nagaraj V., Mandi T., Luan C., Tang Y., Axelsson A.S., Li D., Rosengren A.H., Renstrom E., Zhang E. Eukaryotic translation initiation factor 3 subunit e controls intracellular calcium homeostasis by regulation of cav1.2 surface expression. PLoS ONE 2013, 30:e64462.
111. Morris C., Tonimatsu H., Richard D.J., Cluet D., Burma S., Khanna K.K., Jalinot P. INT6/eIF3e interacts with ATM and is required for proper execution of the DNA damage response in human cells. Cancer Res. 2006, 72:2006-2016.
112. Traicoff J.L., Chung J.Y., Braunschweig T., Mazo I., Shu Y., Ramesh A., D'Amico M.W., Glaperin M.M., Knezevic V., Hewitt S.M. Expression of EIF3-p48/INT6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression. J. Biomed. Sci. 2007, 14:395-405.
113. Morris C., Wittmann J., Jack H.M., Jalinot P. Human INT6/eIF3e is required for nonsense-mediated mRNA decay. EMBO Rep. 2007, 8:596-602.
114. Shi J., Kahle A., Hershey J.W.B., Honchak B.M., Warneke J.A., Leong S.P., Nelson M.A. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 2006, 25:4923-4936.
115. Doldan A., Chandramouli A., Shanas R., Bhattacharyya A., Cunningham J.T., Nelson M.A., Shi J. Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol. Carcinog. 2008, 47:235-244.
116. Doldan A., Chandramouli A., Shanas R., Bhattacharyya A., Leong S.P., Nelson M.A., Shi J. Loss of the eukaryotic initiation factor 3f in melanoma. Mol. Carcinog. 2008, 47:806-813.
117. Marchione R., Leibovitch S.A., Lenormand J.L. The translational factor eIF3f: the ambivalent eIF3 subunit. Cell. Mol. Life Sci. 2013, 10.1007/s00018-013-1263-y.
118. Sanchez A.M., Csibi A., Raibon A., Docquier A., Lagirand-Cantaloube J., Leibovitch M.P., Leibovitch S.A., Bernardi H. eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle. Int. J. Biochem. Cell Biol. 2013, 45:2158-2162.
119. Shi J., Feng Y., Goulet A.C., Vaillancourt R.R., Sachs N.A., Hershey J.W.B., Nelson M.A. The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J. Biol. Chem. 2003, 278:5062-5071.
120. Shi J., Hershey J.W.B., Nelson M.A. Phosphorylation of the eukarhyotic initiation factor 3f by cyclin dependent protein kinase 11 during apoptosis. FEBS Lett. 2009, 583:971-977.
121. Valente S.T., Gilmartin G.M., Venkatarama K., Arriagada G., Goff S.P. HIV-1 mRNA 3' end processing is distinctively regulated by eIF3f, CDK11 and splice factor 9G8. Mol. Cell 2009, 36:279-289.
122. Walter B.M., Nordhoff C., Varga G., Goncharenko G., Schneider S.W., Ludwig S., Wixler V. Mss4 protein is a regulator of stress response and apoptosis. Cell Death Dis. 2012, 3:e297.
123. Chu Y.L., Wu X., Xu Y., Her C. MutS homologue hMDH4: interaction with eIF3f and a role in NHEJ-mediated DSB repair. Mol. Cancer 2013, 12:51.
124. Lee J.P., Brauweiler A., Rudolph M., Hooper J.E., Drabkin H.A., Gemmill R.M. The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol. Cancer Res. 2010, 8:93-106.
125. Nupponen N.N., Porkka K., Kakkola L., Tanner M., Peersson K., Borg A., Isola J., Visakorpi T. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am. J. Pathol. 1999, 154:1777-1783.
126. Saramaki O., et al. Amplication of EIF3S3 gene is associated with advanced stage in prostate cancer. Am. J. Pathol. 2001, 159:2089-2094.
127. Cappuzzo F., Varella-Garcia M., Rossi E., Gajapathy S., Valente M., Drabkin H.A., Gemmill R. MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitnib. J. Thorac. Oncol. 2009, 4:472-478.
128. Okamoto H., Yasui K., Zhao C., Arii S., Inazawa J. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 2003, 38:1242-1249.
129. Tomlinson I.P., Webb E., Carvajal-Carmona L., Broderick P., Howarth K., et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet. 2008, 40:623-630.
130. Pittman A.M., Naranjo S., Jalava S.E., Twiss P., Ma Y., Olver B., Lloyd A., Vijayakrishnan J., Qureshi M., Brderick P., van Wezel T., Morreau H., Tuupanen S., Aaltonen L.A., Alonso M.E., Mnzanares M., Gavilan A., Visakorpi T., Gomez-Skarmeta J.L., Houlston R.S. Allelic variation at the 8q23.3 colorectal cancer rick locus functions as a cis-acting regulator of EIF3H. PLoS Genet. Sep 16 2010, 6(9). (doi.pii: e1001126).
131. Hutter C.M., Chang-Claude J., Slattery M.L., Pflugeisen B.M., Lin Y., Duggan D., Nanet H., Lemire M., et al. Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res. 2012, 72:2036-2044.
132. Zhang L., Smit-McBride Z., Pan X., Hershey J.W.B. An oncogenic role for the human translation initiation factor eIF3h. J. Biol. Chem. 2008, 283:24047-24060.
133. Andaya A., Villa N., Weitao J., Fraser C.S., Leary J. Phosphorylation stoichiometries of human eukaryotic initiation factors. Int. J. Mol. Sci. 2014, 15:11523-11538.
134. Chaudhuri J., Maitra U., Evans T. Translation initiation factor eIF3h targets specific transcripts to polysomes during embryogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:9818-9823.
135. Zhou F., Roy B., Dunlap J.R., Enganti R., von Arnim A.G. Translational control of Arabidopsis meristem stability and organogenesis by the eukaryotic translation factor eIF3h. PLoS ONE 2014, 9:e95396.
136. Matsuda S., Kasumata R., Okuda T., Yamamoto T., Miyazaki K., Senga T., Machida K., Thant A.A., Nakatsugawa S., Hamaguchi M. Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer. Cancer Res. 2000, 60:13-17.
137. Rauch J., Ahlemann M., Schaffrik M., Mack B., Ertongur S., Andratschke M., Zeidler R., Lang S., Gires O. Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem. Biophys. Res. Commun. 2004, 323:156-162.
138. Huang J.-S., Chao C.-C., Su T.-L., Yeh S.-H., Chen D.-S., Chen C.-T., Chen P.-J., Jou Y.-S. Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2004, 315:950-958.
139. Wang Y.W., Lin K.T., Chen S.C., Gu D.L., Chen C.F., Tu P.H., Jou Y.S. Overexpressed-eIF3i interacted and activated oncogenic Akt1 Is a theranostic target in human hepatocellular carcinoma. Hepatology 2013, 10.1002/hep.26352.
140. Bernardini S., Melino G., Saura F., Anniechiarico-Peruzzelli M., Motti C., Cortese C., Federici G. Expression of co-factors (SMRT and Trip-1) for retinoic acid receptors in human neuroectodermal cell lines. Biochem. Biophys. Res. Commun. 1997, 234:278-282.
141. Joseph P., Lei Y.X., Whong W.Z., Ong T.M. Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res. 2002, 62:703-707.
142. Ahlemann M., Ahlemann R., Lang S., Mack B., Muenz M., Gires O. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation. Mol. Carcinog. 2006, 45:957-967.
143. Chen R.H., Miettinen P.J., Maruoka E.M., Choy L., Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature 1995, 377:548-552.
144. Goh S.H., Hong S.H., Lee B.C., Ju M.H., Jeong J.S., Cho Y.R., Kim I.H., Lee Y.S. eIF3m expression influences the regulation of tumorigenesis-related genes in human colon cancer. Oncogene 2011, 30:398-409.
145. Charpentier E., Doudna J.A. Biotechnology: rewriting a genome. Nature 2013, 495:50-51.